Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.38 |
| ▸ | ADH1B | P00325 | 1/20 | 0.37 |
| ▸ | ADH1C | P00326 | 1/20 | 0.37 |
| ▸ | ADH1A | P07327 | 1/20 | 0.37 |
| ▸ | ADH4 | P08319 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | ANPEP | P15144 | 2/20 | 0.34 |
| ▸ | ERAP2 | Q6P179 | 2/20 | 0.34 |
| ▸ | RAD52 | P43351 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | CXCR4 | P61073 | 2/20 | 0.33 |
| ▸ | CXCL12 | P48061 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL479254 | 1.00 | DPP7 (0.52) | DPP7KDM4EALDH1A1HSD17B10HRH3 | |
| SCHEMBL7533868 | 1.00 | DPP7 (0.52) | DPP7KDM4EALDH1A1HSD17B10HRH3 | |
| SCHEMBL1485739 | 1.00 | DPP7 (0.52) | DPP7KDM4EALDH1A1HSD17B10HRH3 | |
| SCHEMBL14473427 | 1.00 | DPP7 (0.52) | DPP7KDM4EALDH1A1HSD17B10HRH3 | |
| Ammonia Solution, Strong SCHEMBL6390287 | 0.98 | DPP7 (0.50) | DPP7KDM4EALDH1A1HSD17B10HRH3 | |
| Hydrochloric Acid SCHEMBL2864272 | 0.98 | DPP7 (0.50) | DPP7KDM4EALDH1A1HSD17B10HRH3 | |
| SCHEMBL818299 | 0.97 | — | — | |
| Methylamine SCHEMBL6863587 | 0.93 | DPP7 (0.47) | DPP7KDM4EALDH1A1HSD17B10HRH3 | |
| SCHEMBL538845 | 0.92 | — | — | |
| Cyclohexylamine SCHEMBL6863571 | 0.89 | DPP7 (0.44) | DPP7KDM4EALDH1A1HSD17B10HRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1223161-A2 | Method to stabilise and/or lower the color number of alkenyl compounds | BASF AKTIENGESELLSCHAFT (DE) | 2002-07-17 | — | — | EP | disclosed |
| US-20020091254-A1 | Stabilizing and/or lowering the color number of alkenyl compounds | BASF AKTIENGESELLSCHAFT (DE) | 2002-07-11 | — | — | US | disclosed |
| US-6384216-B1 | CARRYING OUT TWO DISTILLATIONS IN WHICH THE PURIFIED ALKENYL COMPOUNDS OBTAINED FROM GAS PHASE BY CONDENSATION, WHERE THE TIME BETWEEN FIRST DISTILLATION AFTER SYNTHESIS OF ALKENYL COMPOUNDS AND FURTHER DISTILLATION | BASF AKTIENGESELLSCHAFT (DE) | 2002-05-07 | — | — | US | disclosed |
| US-20020038059-A1 | PURIFICATION OF ALKENYL COMPOUNDS | BASF AKTIENGESELLSCHAFT (DE) | 2002-03-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020091254-A1 | Stabilizing and/or lowering the color number of alkenyl compounds | SOD1, NOX4, CAT | DPP7 3663/4885KDM4E 861/4885ALDH1A1 462/4885 |
| US-20020038059-A1 | PURIFICATION OF ALKENYL COMPOUNDS | TPR, AGPAT5, PCNA | DPP7 728/4885KDM4E 1934/4885ALDH1A1 1108/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.